This article examines the immune system's reaction to a specific cancer treatment known as intracerebroventricular CAR T cell therapy in patients with recurrent glioblastoma. Researchers utilized advanced single-cell RNA sequencing and spectral cytometry to observe how both the engineered cells and the patient's own endogenous immune compartment change after infusion. The study highlights that the...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动